Improving Vaccinations for Young Children (IVY) (IVY)

May 6, 2020 updated by: Elizabeth Williams, Vanderbilt University Medical Center
The IVY project focuses on improving combination 10 vaccine rates for Tennessee children through an educational and quality improvement intervention rolled out through a stepped-wedge cluster randomized trial.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

The proposed work seeks to improve Combination 10 vaccination rates for Tennessee children at 2 years of age through the development and implementation of a new program, Improving Vaccination for Young Children (IVY). Through a collaboration with the Cumberland Pediatrics Foundation (CPF), a non-profit company focused on improving health care services for Tennessee's children, investigators plan to adapt and disseminate existing CoVER educational materials for community pediatric providers and clinical staff, and develop and implement targeted quality improvement (QI) initiatives.

A.3. Specific Objectives:

  1. Design interactive web-based modules individualized for two groups (pediatric providers and pediatric clinical staff) to educate on key vaccine topics. Modules will include information related to 1) diseases vaccines are targeting, including influenza 2) vaccine contraindications, common misconceptions, and vaccine safety, 3) communication techniques, 4) vaccine schedules and catch up rules, and 5) exemptions, school requirements, and practice dismissal.
  2. Design an in-person QI coaching session incorporating key drivers for improved vaccination rates. The session will be developed using the 4Pillars™ Practice Transformation Program (4Pillars™) and will include introduction of 1) acute visits for vaccine catch up, 2) team-based care practices, 3) standing vaccination record review and vaccination orders, and 4) reminder/recall systems.
  3. Implement educational modules and QI coaching session at specific time points within the context of a stepped wedge cluster randomized trial (SW-CRT). Combination 10 [(Combo 10)] vaccine rates will be collected monthly from the Electronic Health Record (EHR) of recruited practices for eligible children turning 2 years of age. Vaccine rates will be compared between practices monthly within the SW-CRT design. Rates will also be evaluated by practice over time.

Study Type

Interventional

Enrollment (Actual)

8

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Tennessee
      • Nashville, Tennessee, United States, 37232
        • Sarah E Williams

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • pediatric clinics
  • serving children at minimum up to age 2
  • located in Tennessee

Exclusion Criteria:

-none

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Step Wedge Randomized Group 1
Includes two pediatric practices randomized to the first step of the step-wedge randomized trial
a combination of practice education and quality improvement interventions
Experimental: Step Wedge Randomized Group 2
Includes two pediatric practices randomized to the second step of the step-wedge randomized trial
a combination of practice education and quality improvement interventions
Experimental: Step Wedge Randomized Group 3
Includes two pediatric practices randomized to the third step of the step-wedge randomized trial
a combination of practice education and quality improvement interventions
Experimental: Step Wedge Randomized Group 4
Includes two pediatric practices randomized to the fourth step of the step-wedge randomized trial
a combination of practice education and quality improvement interventions

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Combination 10 vaccination rates in 2 year old children
Time Frame: Assessing change in combination 10 vaccination rates in 2 year old children up to 12 months
The primary outcome is individual patient-level receipt of all vaccinations [Combo 10 (binary, yes/no)] for children turning 2 years of age in prior month.
Assessing change in combination 10 vaccination rates in 2 year old children up to 12 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Combination 3 vaccination rates in 2 year old children
Time Frame: Assessing change in combination 3 vaccination rates in 2 year old children up to 12 months
The primary outcome is individual patient-level receipt of all vaccinations [Combo 3 (binary, yes/no)] for children turning 2 years of age
Assessing change in combination 3 vaccination rates in 2 year old children up to 12 months
Additional sub analyses of combination 10 vaccination rates (excluding flu vaccine) in 2 year old children
Time Frame: Assessing change in combination 10 vaccination (excluding flu vaccine) rates in 2 year old children up to 12 months
We will adjust our data and analyze combo 10 vaccination rates minus influenza vaccine.
Assessing change in combination 10 vaccination (excluding flu vaccine) rates in 2 year old children up to 12 months
Additional sub analyses of combination 10 vaccination rates in 2 year old children adjusting for proportion of practice who complete educational training
Time Frame: Assessing how "dose" of educational training affects change in combination 10 vaccination rates in 2 year old children up to 12 months
We will determine proportion of the practice who completed the educational training and conduct a dose analysis.
Assessing how "dose" of educational training affects change in combination 10 vaccination rates in 2 year old children up to 12 months
Additional sub analyses of combination 10 vaccination rates in 2 year old children adjusting for whether practice represents a community or academic population
Time Frame: Assessing change in combination 10 vaccination rates in 2 year old children up to 12 months, adjusting for educational "dose"
We will adjust for the bivariate variable of community versus academic population within our analysis model. Community practices are those that are recruited by our partner Cumberland Pediatric Foundation and academic practices are those directly affiliated with Vanderbilt.
Assessing change in combination 10 vaccination rates in 2 year old children up to 12 months, adjusting for educational "dose"

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Sarah E Williams, MD, MPH, Vanderbilt University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 1, 2019

Primary Completion (Actual)

February 28, 2020

Study Completion (Actual)

February 28, 2020

Study Registration Dates

First Submitted

December 9, 2019

First Submitted That Met QC Criteria

December 16, 2019

First Posted (Actual)

December 18, 2019

Study Record Updates

Last Update Posted (Actual)

May 7, 2020

Last Update Submitted That Met QC Criteria

May 6, 2020

Last Verified

May 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • 190032

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Vaccination Refusal

Clinical Trials on IVY

Subscribe